This hypothesis was supported by Western blot analysis when HBsAg treatment increased the protein levels of fibronectin and vimentin in EBV-positive NPC cells but not in EBV-negative NPC cells. The gene discussed is FN1; the disease is nasopharyngeal carcinoma.